Chemoradiotherapy, Adjuvant
"Chemoradiotherapy, Adjuvant" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Combined chemotherapy and radiotherapy given to augment some other form of treatment such as surgery. It is commonly used in the therapy of cancer.
| Descriptor ID |
D059186
|
| MeSH Number(s) |
E02.186.079.500 E02.319.164.500 E02.815.160.500
|
| Concept/Terms |
Chemoradiotherapy, Adjuvant- Chemoradiotherapy, Adjuvant
- Adjuvant Chemoradiotherapies
- Chemoradiotherapies, Adjuvant
- Adjuvant Radiochemotherapy
- Adjuvant Radiochemotherapies
- Radiochemotherapies, Adjuvant
- Radiochemotherapy, Adjuvant
- Adjuvant Chemoradiotherapy
|
Below are MeSH descriptors whose meaning is more general than "Chemoradiotherapy, Adjuvant".
Below are MeSH descriptors whose meaning is more specific than "Chemoradiotherapy, Adjuvant".
This graph shows the total number of publications written about "Chemoradiotherapy, Adjuvant" by people in this website by year, and whether "Chemoradiotherapy, Adjuvant" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 1 | 1 | 2 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 0 | 2 | 2 |
| 2016 | 3 | 1 | 4 |
| 2017 | 1 | 1 | 2 |
| 2020 | 1 | 0 | 1 |
| 2021 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemoradiotherapy, Adjuvant" by people in Profiles.
-
Late cardiac toxicity of neo-adjuvant chemoradiation in esophageal cancer survivors: A prospective cross-sectional pilot study. Radiother Oncol. 2022 02; 167:72-77.
-
Factors Associated With Risk of Body Image-Related Distress in Patients With Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2021 12 01; 147(12):1019-1026.
-
Microscopic Extranodal Extension in HPV-Negative Head and Neck Cancer and the Role of Adjuvant Chemoradiation. Otolaryngol Head Neck Surg. 2021 10; 165(4):536-549.
-
Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2020 12 01; 146(12):1109-1119.
-
A comprehensive comparative analysis of treatment modalities for sinonasal malignancies. Cancer. 2017 Aug 15; 123(16):3040-3049.
-
Diffusion-weighted magnetic resonance imaging in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. Eur J Surg Oncol. 2017 Jul; 43(7):1324-1329.
-
Evaluation of Quality Metrics for Surgically Treated Laryngeal Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2016 12 01; 142(12):1154-1163.
-
Association of Adjuvant Chemoradiotherapy vs Radiotherapy Alone With Survival in Patients With Resected Major Salivary Gland Carcinoma: Data From the National Cancer Data Base. JAMA Otolaryngol Head Neck Surg. 2016 11 01; 142(11):1100-1110.
-
Impact of adjuvant chemoradiation on survival in patients with resectable cholangiocarcinoma. HPB (Oxford). 2016 10; 18(10):843-850.
-
Treating Locally Advanced Cervical Cancer With Concurrent Chemoradiation Without Brachytherapy in Low-resource Countries. Am J Clin Oncol. 2016 Feb; 39(1):92-7.